These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2945420)

  • 41. Efficacy of Terminalia arjuna in chronic stable angina: a double-blind, placebo-controlled, crossover study comparing Terminalia arjuna with isosorbide mononitrate.
    Bharani A; Ganguli A; Mathur LK; Jamra Y; Raman PG
    Indian Heart J; 2002; 54(2):170-5. PubMed ID: 12086380
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of a new metabolic modulator, ranolazine, on exercise tolerance in angina pectoris patients treated with beta-blocker or diltiazem.
    Cocco G; Rousseau MF; Bouvy T; Cheron P; Williams G; Detry JM; Pouleur H
    J Cardiovasc Pharmacol; 1992 Jul; 20(1):131-8. PubMed ID: 1383622
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy.
    Krumenacker M; Roland E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S93-102. PubMed ID: 1282184
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A pilot double-blind randomized placebo-controlled study of molsidomine 16 mg once-a-day in patients suffering from stable angina pectoris: correlation between efficacy and over time plasma concentrations.
    Messin R; Fenyvesi T; Carreer-Bruhwyler F; Crommen J; Chiap P; Hubert P; Dubois C; Famaey JP; Géczy J
    Eur J Clin Pharmacol; 2003 Jul; 59(3):227-32. PubMed ID: 12734607
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of a new coronary vasodilator, nicorandil, on variant angina pectoris.
    Kishida H; Murao S
    Clin Pharmacol Ther; 1987 Aug; 42(2):166-74. PubMed ID: 2955996
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dipyridamole in chronic stable angina pectoris; a randomized, double blind, placebo-controlled, parallel group study.
    Picano E;
    Eur Heart J; 2001 Oct; 22(19):1785-93. PubMed ID: 11549300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Safety profile of an anti-anginal agent with potassium channel opening activity: an overview.
    Roland E
    Eur Heart J; 1993 Jul; 14 Suppl B():48-52. PubMed ID: 8370373
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acute and chronic efficacy of low-dose nitroglycerin patches in stable angina pectoris.
    Rezaković DE; Lakatos S; Stalec J; Pavicić L
    Z Kardiol; 1986; 75 Suppl 3():90-5. PubMed ID: 3099489
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of transdermal nitroglycerin in combination with an ACE inhibitor in patients with chronic stable angina pectoris.
    Muiesan ML; Boni E; Castellano M; Beschi M; Cefis G; Cerri B; Verdecchia P; Porcellati C; Pollavini G; Agabiti-Rosei E
    Eur Heart J; 1993 Dec; 14(12):1701-8. PubMed ID: 8131770
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nicorandil for angina.
    Drug Ther Bull; 1995 Dec; 33(12):89-92. PubMed ID: 8777891
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of dipyridamole therapy on myocardial ischemia in patients with stable angina pectoris receiving concurrent anti-ischemic therapy.
    Barbour MM; Garber CE; Agarwal KC; Malhotra R; Heller GV
    Am J Cardiol; 1992 Feb; 69(5):449-52. PubMed ID: 1736604
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Felodipine in chronic stable angina: a randomized, double-blind, placebo-controlled, crossover study.
    Sangiorgio P; Di Pasquale G; Savonitto S; Urbinati S; Rubboli A; Cavallotti G; Pinelli G; Bracchetti D
    Eur Heart J; 1990 Nov; 11(11):1011-7. PubMed ID: 2282920
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antianginal and anti-ischemic effects of mibefradil in the treatment of patients with chronic stable angina pectoris.
    Alpert JS; Bakx AL; Braun S; Frishman WH; Schneeweiss A; Tzivoni D; Kobrin I
    Am J Cardiol; 1997 Aug; 80(4B):20C-26C. PubMed ID: 9286850
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study.
    Sellier P; Broustet JP
    Am J Cardiovasc Drugs; 2003; 3(5):361-9. PubMed ID: 14728070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The effect of an angiotensin-converting enzyme inhibitor and a K+(ATP) channel opener on warm up angina.
    Edwards RJ; Redwood SR; Lambiase PD; Marber MS
    Eur Heart J; 2005 Mar; 26(6):598-606. PubMed ID: 15618027
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial.
    Ruzyllo W; Tendera M; Ford I; Fox KM
    Drugs; 2007; 67(3):393-405. PubMed ID: 17335297
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of theophylline, atenolol and their combination on myocardial ischemia in stable angina pectoris.
    Crea F; Pupita G; Galassi AR; el-Tamimi H; Kaski JC; Davies GJ; Maseri A
    Am J Cardiol; 1990 Nov; 66(17):1157-62. PubMed ID: 2239717
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of dipyridamole at the usual oral dose on exercise-induced myocardial ischemia in stable angina pectoris.
    Tsuya T; Okada M; Horie H; Ishikawa K
    Am J Cardiol; 1990 Aug; 66(3):275-8. PubMed ID: 2195863
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improved exercise tolerance after propranolol, diltiazem or nifedipine in angina pectoris: comparison at 1, 3 and 8 hours and correlation with plasma drug concentration.
    Chaitman BR; Wagniart P; Pasternac A; Brevers G; Scholl JM; Lam J; Methe M; Ferguson RJ; Bourassa MG
    Am J Cardiol; 1984 Jan; 53(1):1-9. PubMed ID: 6362383
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Anti-angina activity of potassium-channel activators].
    Chiariello M; Duilio C; Ambrosio G
    Cardiologia; 1993 Dec; 38(12 Suppl 1):459-63. PubMed ID: 8020048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.